A validated sfGFP fluorescence assay to monitor Escherichia coli extract productivity for cell- free biomanufacturing

Cell-free protein synthesis represents a rapidly developing class of manufacturing technologies reported to enable rapid, scalable, decentralized, and versatile protein production for drug products. However, the batch-to-batch variability of the cell extract raw material used for the cell-free reaction may affect the production consistency and product quality. Therefore, we developed and validated an in vitro superfolder green fluorescent protein (sfGFP) productivity assay to quantify and compare the protein-synthesis output of Escherichia coli (E. coli) –derived cell extract batches for suitability prior to their use in establishing a cell-free manufacturing platform. Here, we report a validated quantitative fluorometric assay that is fit-for-purpose for monitoring batch-to-batch variation in extract productivity. This method was evaluated following International Council for Harmonisation (ICH) Q2(R2) and Q14 guidelines to support reproducibility and comparability across laboratories. Assay performance was assessed for specificity, linearity, limit of detection, limit of quantitation, accuracy, robustness, and precision. The assay exhibited a working range of (6.25 to 200) mg/L for sfGFP produced by the cell free reaction with linearity (R² ≥ 0.99) and intermediate precision (< 25% relative standard deviation). To demonstrate the practical application of this method across different laboratories, the assay was applied to monitor extract performance during process scale-up by comparing 1 L laboratory-scale batches produced at FDA with 50 L pilot-scale batches produced at DEVCOM-CBC. To support analytical comparability and standardization efforts across the cell-free manufacturing community, all data and methodological protocols from this study have been made available to academic, institutional, and commercial cell-free manufacturing stakeholders at no cost. These data support the utility of this in vitro sfGFP assay to characterize extract productivity and to inform strategies for monitoring extract performance in E. coli cell-free manufacturing workflows.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-21
DOI
https://doi.org/10.21203/rs.3.rs-11472297/v1
Primary Topic
RNA and protein synthesis mechanisms
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

A validated sfGFP fluorescence assay to monitor Escherichia coli extract productivity for cell- free biomanufacturing

Uriel Ortega‐Rodriguez, Stephanie D. Cole, Jordan D. Pritts, João Pedras-Vasconcelos et al.
Research Square
RNA and protein synthesis mechanisms
preprint

A validated sfGFP fluorescence assay to monitor Escherichia coli extract productivity for cell- free biomanufacturing

Uriel Ortega‐Rodriguez, Stephanie D. Cole, Jordan D. Pritts, João Pedras-Vasconcelos, Casey L. Kohnhorst, Tongzhong Ju, V. Ashutosh Rao, Talia Faison, Thomas G. Biel, Fernanda Piorino, Eugenia F. Romantseva, Ian L. McWilliams, Elizabeth A. Strychalski, Svetlana N. Petrovskaya, Tylee Houchens, Patrick Lynch, Matthew Flores, Kathrine Rhea, Jennifer Lee, Bruce Huang, Yousof Zidan
preprint en

Abstract

Cell-free protein synthesis represents a rapidly developing class of manufacturing technologies reported to enable rapid, scalable, decentralized, and versatile protein production for drug products. However, the batch-to-batch variability of the cell extract raw material used for the cell-free reaction may affect the production consistency and product quality. Therefore, we developed and validated an in vitro superfolder green fluorescent protein (sfGFP) productivity assay to quantify and compare the protein-synthesis output of Escherichia coli (E. coli) –derived cell extract batches for suitability prior to their use in establishing a cell-free manufacturing platform. Here, we report a validated quantitative fluorometric assay that is fit-for-purpose for monitoring batch-to-batch variation in extract productivity. This method was evaluated following International Council for Harmonisation (ICH) Q2(R2) and Q14 guidelines to support reproducibility and comparability across laboratories. Assay performance was assessed for specificity, linearity, limit of detection, limit of quantitation, accuracy, robustness, and precision. The assay exhibited a working range of (6.25 to 200) mg/L for sfGFP produced by the cell free reaction with linearity (R² ≥ 0.99) and intermediate precision (< 25% relative standard deviation). To demonstrate the practical application of this method across different laboratories, the assay was applied to monitor extract performance during process scale-up by comparing 1 L laboratory-scale batches produced at FDA with 50 L pilot-scale batches produced at DEVCOM-CBC. To support analytical comparability and standardization efforts across the cell-free manufacturing community, all data and methodological protocols from this study have been made available to academic, institutional, and commercial cell-free manufacturing stakeholders at no cost. These data support the utility of this in vitro sfGFP assay to characterize extract productivity and to inform strategies for monitoring extract performance in E. coli cell-free manufacturing workflows.

Research Square
United States Department of the Army (US), United States Food and Drug Administration (US), National Institute of Standards and Technology (US), Defense Threat Reduction Agency (US)
RNA and protein synthesis mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon